Exclusive Online Content
New Drugs Could Drive Celiac Disease Treatment Market Value Beyond $550 Million
The launches of Alba/Teva’s larazotide acetate and Alvine/AbbVie’s latiglutenase for treating celiac disease could drive sales in the US and five major European markets (5EU:…
Global Market for MicroRNA Research Tools to Reach $1 Billion by 2019
The last decade witnessed significant advancement in microRNA (miRNA) research leading to identification of novel miRNA genes, validation of miRNA targets and delineation of the…
Peter Bigelow Elected as PBOA's First-Ever Chairman
The Pharma & Biopharma Outsourcing Association (PBOA), a new non-profit trade association devoted to advancing the interests of CMOs, CDMOs and other service providers, has…
Mystic Pharmaceuticals Introduces ArrowFish Nasal Vaccine and Drug Delivery System
Mystic Pharmaceuticals, Inc. today announced the availability of its Arrowfish™ nasal drug and biologic delivery system. This new generation delivery system utilizes Mystic’s patented VersiDoser®…
Global Non-Hodgkin Lymphoma Therapeutics Market Value to Hit $9.2 Billion
The global Non-Hodgkin Lymphoma (NHL) treatment market will increase in value from $5.6 billion in 2013 to $9.2 billion by 2020, representing a Compound Annual…
Morrison & Foerster's BioMeter Index Shows Reemergence of Late-Stage Deals
Morrison & Foerster returns with its Q3 edition of BioMeter, which reveals a big jump in the number of deals and average payments for Phase…
Pharmaceutical Industry Feeling Force of Tax Inversion Legislation, says GlobalData Analyst
The recent termination of AbbVie’s deal to acquire Shire makes this pharmaceuticals’ first major casualty of new US tax inversion legislation, and has jolted the…
Horizon Discovery Group Launches Collection of Highly Characterized Patient-Derived Xenograft Models of Breast Cancer
Horizon Discovery Group plc (Horizon), a leading provider of products, services and technologies in the field of genome engineering, today announced the launch of its…
Changes & Trends in Solubilization Outsourcing
By: Marshall Crew, PhD, President & CEO, Agere Pharmaceuticals, Inc. Approved drugs over the last thirty-five years are evidence that there is a…
Ultra-Rapid-Acting Insulin Formulations Will Revolutionize Type 1 Diabetes Treatment Market by 2019
LONDON, UK (GlobalData), 7 October 2014 - Ultra-rapid formulations of the currently marketed rapid-acting insulin analogs have the clear potential to radically change the insulin…
Unilife Signs 15-Year Commercial Supply Agreement for Wearable Injectors With Sanofi
York, PA. – October 6, 2014 - Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer and supplier of injectable drug delivery systems, announced…
Innovation-by-Outsourcing: Impact on Solubilization Services
By: Marshall Crew, PhD, President & CEO, Agere Pharmaceuticals, Inc. In 2008, research utilizing data from the Business Dynamics Statistics of the US Census…
Merck KgaA to Acquire Sigma-Aldrich for $17 Billion
Merck KgaA, a public company based in Darmstadt, Germany, announced it will acquire St.Louis, Mo. based Sigma-Aldrich for $17 billion. This is the largest acquisition…
Global Market for Nanoparticles Instrumentation to Reach $7.8 Billion
The nanoparticle analysis market presents an increasingly significant part of the overall pharmaceutical product analysis market worldwide. In the past two decades, the science of…
Global Market for Cancer Profiling Technologies to Reach Nearly $54.8 Billion
The global healthcare industry is seeing new developments, improved point-of-care diagnostics, cost-effective treatment modalities, and advances in personalized medicine, which not only offer efficient early…
Implementing Innovations in Injectable Drug Delivery With the User & Pharmaceutical Manufacturer in Mind
By: John A. Merhige, Chief Commercial Officer, and Dan Thayer, Technology Director, Credence MedSystems, Inc. The Current Climate Change is hard. This is true in…
Asia-Pacific’s Glioblastoma Multiforme Treatment Market Value to More Than Double by 2020
Asia-Pacific’s Glioblastoma Multiforme Treatment Market Value to More Than Double by 2020 The Glioblastoma Multiforme (GBM) therapeutics market in Asia-Pacific (APAC) will more than…
Australia’s Pharma Sector to Grow to $32.1 Billion
Australia’s healthcare market is set to grow to an impressive $42.5 billion by 2020, driven by universal healthcare coverage provided by Medicare and good access…
Global Market for Nanoparticles in Biotechnology & Pharmaceuticals to Reach $79.8 Billion
The nanoparticle drug/delivery market presents an increasingly significant part of the overall pharmaceutical product market worldwide. The most rapid advances have been made in drug research…
